Read Abraham’s full essay on her diagnosis and journey with colon cancer with interviews from other survivors, advocates, and clinicians, including Dr. John Marshall.

Liquid, Tissue, or Both? Expediting Next-Generation Sequencing Results to Guide Treatment Selection in Patients With Metastatic Colorectal Cancer dailynews.ascopubs.org/do/liquid-ti...

Fit, Young, and at Risk for Precancerous Colon Lesions? www.medpagetoday.com/gastroentero...

Join us tomorrow morning, Friday, June 27th, from 9:00- 10:30 am, to review research from the #ASCO25 Annual Meeting. We will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers via Zoom. Register now: bit.ly/4k63Swd to receive the link.

"Badge-up" with @marshalj23.bsky.social of @georgetownlombardi.bsky.social as he discusses #ASCO25 with @clinicalcaresol.bsky.social. Watch now: clinicalcaresolutions.net/activities/o...

The Hidden Barriers Holding Back Cancer's Most Promising Treatments: Samir N. Khleif, MD of @georgetownlombardi.bsky.social shares his thoughts on the pace of innovation in immune checkpoint inhibitors. time.com/7292783/canc...

We are excited to celebrate our 10th Annual GI Cancer Patient Summit with Hope Connections for Cancer Support and @georgetownlombardi.bsky.social on Saturday, July 12, 2025, from 10:00 am- 1:00 pm EST. The summit provides information and tools to manage cancer care. Learn more: bit.ly/GISummit25

EGFR Inhibitors in the Treatment of Stage IV CRC: Benjamin Weinberg, MD, discusses with @medscape.com Hematology and Oncology Decision Point. decisionpoint.medscape.com/oncology/vie...

Join @medstarhealth.bsky.social for the 2025 Esophageal Symposium. Attendees will gain insights into identifying the pathophysiology associated with esophageal conditions, as well as guidance on testing, indications for therapy, and available endoscopic and surgical treatments. bit.ly/3FHX6On

After #ASCO25, stay up-to-date on the latest GI Cancer Research. View this week's tailored GI Cancer publication output via bit.ly/454GquF and sign up to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub.

Join us to review exciting research from the #ASCO25 Annual Meeting. Drs. Marshall, Weinberg, Noel, and Mukherji will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers on June 27th via Zoom. Register today: bit.ly/4k63Swd @georgetownlombardi.bsky.social.

John L. Marshall, MD, (@marshalj23.bsky.social) discusses unmet needs in the targeted therapy space and the importance of optimizing dosing in colorectal cancer with @targetedonc.bsky.social. www.targetedonc.com/view/unmet-n...

Today, on Clinical Trials Day, we recognize and celebrate the contributions of clinical research professionals in advancing research at Lombardi Comprehensive Cancer Center. The Lombardi Clinical Trials Office provides administrative, nursing, and data management support for clinical trials.

Register today for the 10th Annual GI Cancer Patient Summit on Saturday, July 12, 2025, from 10:00 am- 1:00 pm EST. The summit provides information and tools to manage cancer care. This free event is a partnership with Hope Connections for Cancer Support. bit.ly/GISummit25

Learn more about BellRinger today! Join Team Ruesch as a rider, volunteer, or supporter as we gear up for BellRinger on October 24-25, 2025. 100% of funds raised from BellRinger support cancer research at @georgetownlombardi.bsky.social. bit.ly/RueschBellRinger

This week, we highlighted research by Emil Lou (@cancerassassin1.bsky.social), Modassir S Choudhry, Timothy K Starr, Timothy D Folsom, Jason Bell, Blaine Rathmann, Anthony P DeFeo, Jihyun Kim, Branden S Moriarity, and others published in @thelancetoncol.bsky.social. Learn more: bit.ly/3Fkx2bI.

In this week's Ruesch Center GI Cancers publication search, @marshalj23.bsky.social highlighted research by Julien Taieb, Pierre Laurent-Puig, and others published in the Journal of Clinical Oncology. bit.ly/3Fkx2bI. Learn more: youtu.be/JlqL1f6vyak?...

On Thursday, May 15th, join thousands of commuters in the DMV for Bike to Work Day! BellRinger will host its own stop at Georgetown Waterfront Park. Stop by to learn how to gear up to support critical research at @georgetownlombardi.bsky.social . Register today: bit.ly/4k5BABC.

View this week's tailored GI Cancer publication output via bit.ly/431rg6J. Sign up today to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub. What research excited you this week?

Join Smith Center for the Healing and the Arts, Hope Connections for Cancer Support Community, Washington, D.C., and Cancer Choices for this virtual event on Wednesday, May 21st. Learn more and register today: smithcenter.org/programs-ret...

This week, we highlighted research by Jill P Smith, Narayan Shivapurkar, Wenqiang Chen, Godhanjali Chekuri, Amani Dabney, Kyle Holmes, Hong Cao, Ruvanthi N Kularatne, and Stephan T Stern published in the Journal of Molecular Cancer Therapeutics. Learn more: bit.ly/4lTknwY

Save the Date for the 16th Annual Ruesch Center Symposium- Nov 21-22, 2025! @georgetownlombardi.bsky.social @marshalj23.bsky.social @onclive.bsky.social @medstarhealth.bsky.social

Pancreatic Cancer 2025: After More Than 30 Years, Is That Light on the Horizon? @marshalj23.bsky.social shares insights in the Spring Issue of Oncolytics Today. Read the full article, pages 77-79-https://www.ncoda.org/news/oncolytics-today-spring-2025/

In an interview with Peers & Perspectives in Oncology, Dr. John Marshall discussed treatment approaches and sequencing for refractory colorectal cancer. www.targetedonc.com/view/managin...

This week, we highlighted exciting research by Berend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, Sjoerd M Lagarde, J Jan B van Lanschot, and others published in @thelancetoncol.bsky.social. Learn more: bit.ly/3GkX52V.

Nominations are open for the 2025 Luminary Awards in GI Cancers! Submit your colleagues who have transformed the lives of GI cancer patients. Categories include MedOnc, Pre-clinical, Nursing, Surgery, and Advocacy. Awards will be presented on November 20th in D.C. bit.ly/LuminaryNomination

@marshalj23.bsky.social and @marklewismd.bsky.social discuss how ctDNA clearance rates during and after adjuvant chemotherapy (ACT) in the BESPOKE trial provide critical insights into treatment efficacy and may serve as an early predictor of long-term patient outcomes. bit.ly/4luOsmd

This week, we highlighted research by Zhihao Lu, Wenting Du, Xi Jiao, Lin Shen, and others published in the Journal of Clinical Oncology. Learn more: bit.ly/43KNnAs.

Targeted Therapy Options Sometimes Underutilized in Metastatic CRC. @marshalj23.bsky.social, discusses the sequencing of targeted therapy for refractory metastatic colorectal cancer. www.targetedonc.com/view/targete...

Mass layoffs. Funding cuts. Uncertain futures. @marshalj23.bsky.social unpacks the turmoil hitting federal health agencies and what it means for researchers, clinical trials, and patient care. Who benefits from this chaos, and how can the medical community push back? bit.ly/42nXXLw

'Scientists at the National Institutes of Health demonstrated a promising step toward using a person's immune cells to fight gastrointestinal cancers in a paper in Nature Medicine on Tuesday, the same day the agency was hit with devastating layoffs that left many NIH personnel in tears.'

View this week's tailored GI Cancer publication output via bit.ly/4hoxqmx. Sign up today to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub. What research did you find most compelling this week?

marshalj23.bsky.social and marklewismd.bsky.social discuss how BESPOKE trial results demonstrate significantly improved disease-free survival rates in patients with negative circulating tumor DNA (ctDNA) status compared with those with detectable ctDNA. bit.ly/420Ysfw

Congratulations to Harry Sun (C’26) on being named a 2025 Goldwater Scholar. Sun researches immunology in Dr. Anton Wellstein’s lab @georgetownlombardi.bsky.social, where he has contributed to projects such as liquid biopsy analysis in cancer patients. georgetown.edu/news/junior-...

[email protected] and @marklewismd.bsky.social discuss the BESPOKE trial enrolled a diverse cohort of patients with varying demographic profiles, disease stages, comorbidities, and treatment histories to ensure comprehensive representation for personalized medicine approaches. bit.ly/4jf1O44

Ruesch is gearing up for BellRinger on October 24-25th. This event supports crucial oncology research at @georgetownlombardi.bsky.social. Join us as a rider, volunteer, or supporter and be part of our mission to end cancer. Together, we can make a significant ride.bellringer.org/team/teamrue...

BESPOKE: Study Design, Efficacy End Points, and Methods. cancernetwork.com/view/bespoke... via @marshalj23.bsky.social @marklewismd.bsky.social

The Role of ctDNA in CRC. cancernetwork.com/view/the-rol... via @marshalj23.bsky.social @marklewismd.bsky.social

John L. Marshall, MD, discusses the impact of the SUNLIGHT trial in patients with refractory metastatic colorectal cancer. @marshalj23.bsky.social @georgetownlombardi.bsky.social www.targetedonc.com/view/sunligh...

“Early detection makes this one of the most preventable and treatable cancers,” said Dr. Marcus Noel, medical oncologist at MedStar Georgetown University Hospital and Associate Professor of Medicine in the Department of Medicine at Georgetown University. afro.com/colon-cancer...

Colon cancer is the second-leading cause of cancer-related deaths worldwide. However, most people don’t know when to or how often to get screened. News4’s Melissa Mollet spoke with Dr. Priyanka Kanth to answer common questions about colonoscopies. @medstarhealth.bsky.social @nbcwashington.com

The Ruesch team was thrilled to participate in this year’s #ScopeItOut and to support the work of the Colorectal Cancer Alliance in raising awareness about #ColorectalCancer.

This morning, the Ruesch Center shared resources for #ColorectalAwarenessMonth at @georgetownlombardi.bsky.social. Learn more about the activities we’re engaging in with our partners to raise awareness about colorectal cancer and support the CRC community. ruesch.georgetown.edu/partnerevents/

On Sunday, March 23rd, we are excited to participate in this year’s ScopeItOut and to support the work of the Colorectal Cancer Alliance in raising awareness about #ColorectalCancer. Join the Ruesch team today! bit.ly/3DZzXG9.

View this week's tailored GI Cancer publication output via bit.ly/4hoxqmx. What research was particularly interesting to you this week? Sign up today to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub.

We were excited to join @fightcrc.bsky.social on the National Mall this evening to raise awareness about colorectal cancer at the United in Blue Rally. @georgetownlombardi.bsky.social #ColorectalCancerAwarenessMonth.

Can’t make it to D.C.? No worries – you can still advocate with us! Our easy-to-use action alerts take less than a minute to complete. 💪 #PrioritizeCRC fightcolorectalcancer.org/take-action/

[email protected] reflects on the emotional toll of ongoing uncertainty in healthcare, particularly the impact on both providers and patients in the latest episode of #OncologyUnscripted. @clinicalcaresol.bsky.social bit.ly/3DxloJF

Today is Dress in Blue Day! The Clinical Research Management Office and Ruesch Center faculty @georgetownlombardi.bsky.social wear blue to raise awareness of colorectal cancer and support the CRC community. #ColorectalCancerAwarenessMonth #DressInBlueDay @medstarhealth.bsky.social

The Ruesch Center is proud to support the Colorectal Cancer Alliance at this year's #ScopeItOut on Sunday, March 23, 2025. Learn more about this exciting event and join our team! Registration is free for patients and survivors. impact.ccalliance.org/team/641103